Loading clinical trials...
Loading clinical trials...
A Phase 2 Trial to Study Efficacy and Safety of HBI0101 (NXC-201) CART in Subjects With Multiple Myeloma and Light-Chain Amyloidosis.
Conditions
Interventions
HBI0101 CART
Locations
1
Israel
Hadassah MO
Jerusalem, Israel
Start Date
March 1, 2025
Primary Completion Date
May 15, 2028
Completion Date
May 15, 2030
Last Updated
May 14, 2025
NCT06983951
NCT05978661
NCT02043847
NCT01789242
Lead Sponsor
Polina Stepensky
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions